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Trauma related haemorrhagic anaemia is rarely diagnosed by physical examination alone but typically includes measurement of
blood haemoglobin, one of the most frequently ordered laboratory tests. Recently, noninvasive technologies have been developed
that allow haemoglobin to be measured immediately without the need for intravenous access or having to take venous, arterial, or
capillary blood. Moreover, with these technologies haemoglobin can be continuously measured in patients with active bleeding, to
guide the start and stop of blood transfusions and to detect occult bleeding. Recent studies on the accuracy of the devices showed
promising results in terms of accuracy of hemoglobin measurement compared to laboratory determination. The present review
gives an overview on the technology itself and reviews the current literature on the subject.
1. Background
Trauma related haemorrhagic anaemia is rarely diagnosed
by physical examination alone but typically includes meas-
urement of blood haemoglobin, one of the most frequently
ordered laboratory tests [1, 2]. The need for resuscitation
to achieve adequate tissue perfusion is established by the
patient’s history, on-going bleeding, and clinical signs of
hypovolemia. Haemoglobin and haematocrit measurements,
the conventional means to confirm hypovolemia, are not
always immediately available at the point-of-care and hemo-
dynamic monitoring may not detect relevant blood loss. If
treatment is delayed pending laboratory results or diagnostic
studies, patient outcome can be affected [3–5]. In particulary
in the emergency room, perioperative and critical care set-
tings, rapid and on-going assessment of total haemoglobin
is crucial, in order to quantify blood loss and/or the need
for transfusion [6]. For example, the rapid determination of
blood haemoglobin levels is essential, for the triage of patients
in emergency departments [7], and tracking of changes in
haemoglobin, to detect occult bleeding, has the potential to
be lifesaving during critical care. Therefore, in the hospital
setting, there is growing interest in rapid and continuous
techniques for measuring haemoglobin and changes in hae-
moglobin.
Recently, noninvasive technologies have been developed
that allow haemoglobin to be measured immediately without
the need for intravenous access or having to take venous,
arterial, or capillary blood.Moreover, with these technologies
haemoglobin can be continuously measured in patients with
active bleeding, to guide the start and stop of blood transfu-
sions and to detect occult bleeding.
2. Pulse CO-Oximetry
Pulse CO-Oximetry (Masimo Corp, Irvine, CA, USA) is
the only commercially available technology that allows for
the continuous noninvasive measurement of haemoglobin,
referred to as SpHb. This technology uses a multiple wave-
length, spectrophotometric sensor that may be an adhesive
single use type for continuous monitoring or a reusable
finger clip sensor for spot check assessments. Pulse CO-
Oximetry allows the noninvasive measurement of carboxy-
haemoglobin, methaemoglobin, oxygen content, Pleth Vari-
ability Index, alongwith standard pulse oximetry parameters,
oxygen saturation, pulse rate, and perfusion index [9]. SpHbs
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measurement with Pulse CO-Oximetry is available in a
number of devices designed for the continuous monitoring
at the hospital bedside (Radical-7, Rad-87) or for spot
check applications with hand held devices (Rad-57, Pronto)
(Figure 1).
Most of the studies published thus far on the performance
of SpHb measurement with Pulse CO-Oximetry assess the
accuracy of continuous monitoring in surgical patients.
Berkow and colleagues [8] investigated the accuracy of
SpHb compared to laboratory CO-Oximetry measurement
of 130 arterial blood samples from 29 complex spine surgery
patients and found an absolute bias and standard deviation
of 0.8 ± 0.6 g/dL. Causey et al. [10] studied both surgical
and intensive care patients and found a similar bias of
0.29 g/dL. In a study on 44 patients with acute haemorrhage
during surgery, Lamhaut et al. compared SpHb and capillary
haemoglobin measurement to laboratory determination [11].
The authors obtained a total of 85 measurements, which
showed a bias of only −0.02 g/dL (SD 1.39) and a precision
of 1.11 g/dL (SD 0.83). However, in comparison to laboratory
haemoglobin determination, the percentage of outliers was
significantly higher with noninvasive than with capillary
measurement. Conversely, when Frasca et al. [12] examined
the performance of SpHb in 62 ICU patients providing 471
samples, the bias was 0.0 ± 1.0 g/dL compared to the reference
laboratory haematology analyser. However the bias and
standard deviation of capillary measurement by HemoCue
was 0.3 ± 1.3 g/dL when compared to the reference haema-
tology analyser, significantly higher than SpHb. In general
continuous SpHb monitoring accuracy has been found to be
comparable to invasive point of care capillary measurement,
with some studies showing it to be slightly higher [12] and
some studies showing it to be slightly lower [11] when used in
the operating room and intensive care unit.
There have also been a few studies published in Emer-
gency Room patients. Sjostrand et al. investigated the accu-
racy of SpHb using repetitive controls of venous blood sam-
ples from 30 patients in a tertiary care emergency room [13].
A total of 242 comparative data pairs were obtained, resulting
in a mean deviation of −0.47 g/dL (CI −0.39 to −0.09) for
SpHb. After exclusion of 5 patients due to low signal quality,
the deviation decreased to −0.24 g/dL (CI −0.39 to −0.09).
Chung and colleagues [14] from Inje University Seoul Paik
Hospital in Seoul, Korea, studied the accuracy of SpHb
compared to laboratory measurements from 217 patients
presenting to the emergency department. The correlation
coefficient between laboratory haemoglobin and SpHb was
0.81 in all patients indication of good agreement between
the two methods of measurement. In a prospective study
on 300 emergency patients in France, Gayat et al. compared
spot check SpHb to laboratory analysis of venous blood [15].
The absolute mean difference between SpHb and labora-
tory measurements was 0.56 g/L (confidence interval (CI)
0.41 to 0.69), with a correlation coefficient of 0.80 (CI 0.74 to
0.84). The accuracy of spot check SpHb was also investigated
in the outpatient setting by Raikhel [16]. In a prospective
observational study, the accuracy of SpHbmeasurements and
capillary measurement of haemoglobin were compared to
laboratory haematology analyser measurements from venous
(a) (b)
(c) (d)
Figure 1: Handheld spot check devices, (a) Pronto; (b) Pronto-7, and
continuous monitoring bedside devices, (c) Radical-7 and, (d) Rad-
87.
blood samples. A total of 156 patients were included in the
study, but noninvasive measurement was not possible in 4
patients after two attempts. In the remaining 152 patients,
the mean deviation of SpHb from laboratory determinations
was −0.5 g/dL (standard deviation (SD) 1.0), with a limit of
agreement of −2.5 to 1.5. Results were comparable to haemo-
globin determination using capillary blood, with a mean
deviation of 0.3 g/dL (SD 1.0) and a limit of agreement of −1.7
to 2.3.
Although the vast majority of published evaluations of
SpHb with Pulse CO-Oximetry have been accuracy studies,
the true clinical benefit of the technology may be as a trend
monitor to detect unexpected changes in haemoglobin, such
as with occult bleeding, or to confirm expected changes in
haemoglobin as they occur during and after transfusion of
red blood cells (Figure 2). Some studies have included an
assessment of trend accuracy in the evaluation of SpHb.
Berkow examined the magnitude and direction of changes in
SpHb when laboratory haemoglobin changed by more than
1.5 g/dL between sequential measurements and concluded
that SpHb trended with changes in laboratory haemoglobin
but because the average changes were less than 3 g/dL more
studies were needed [8]. Figure 3 shows continuous SpHb
and intermittent laboratory values during one spinal surgery
case in a 69-year-old female. Colquhoun et al. [17] used
the four-quadrant plot and the polar plot method to assess
trending of SpHb compared to laboratory measurements
in 20 patients undergoing major lumbar and low thoracic
spine surgery. The four-quadrant plot showed that 94% of
SpHb readings outside of the central exclusion zone to
eliminate clinically insignificant changes corresponded with
the correct directionality. Similarly, the polar plot indicated
that 90% of changes in SpHbwere within the limits of accept-
able trending. Frasca et al. [12] used regression plots of
differences in consecutive haemoglobin values reported by
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Table 1: Differences in red blood cell transfusions when clinicians used standard of care blood management or added SpHb monitoring to
guide transfusions in (a) 327 surgery patients with expected low blood loss and (b) 106 surgery patients with expected high blood loss.
(a) Low blood loss surgery (𝑛 = 327) Standard care group (𝑛 = 157) SpHb Group (𝑛 = 170) P value
Patients receiving a transfusion𝑁 (%) 7 (4.5%) 1 (0.6%) 0.03
Total units transfused,𝑁 (mean) 15 (0.10) 1 (0.1) 0.001
(b) High blood loss surgery (𝑛 = 106) Standard care group (𝑛 = 61) SpHb Group (𝑛 = 45) P value
RBC transfusions per subject, mean ± SD units 1.9 ± 2.3 1.0 ± 1.5 <0.001
RBC transfusions per subject receiving a transfusion, mean ± SD units 3.9 ± 1.7 2.3 ± 1.5 <0.01
Transfused patients receiving >3 RBC, % units 73 32 <0.01
Time to transfusion start after need established, mean ± SD min 50.2 ± 7.9 9.2 ± 1.7 <0.001
Sp
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Continuous indication of whether hemoglobin is as follows:
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It may enable:
∙ Earlier interventions (SpHb unexpectedly dropping or lower)
∙ Avoiding interventions (SpHb unexpectedly stable or higher)
Stable → falling
Figure 2: Theoretical model of SpHb monitoring.
SpHb, capillary haemoglobin measurement with HemoCue,
and satellite CO-Oximetry measurements compared to cen-
tral laboratory measurements. SpHb demonstrated the best
trending of the three methods with a concordance coefficient
of 0.79. Concordance coefficients for satellite CO-Oximetry
and HemoCue were 0.74 and 0.76, respectively.
Indeed, it is the continuous data and trending ability that
differentiates this technology from intermittent laboratory
or point of care measurements. In fact, the purpose of con-
tinuous monitoring is not to replace intermittent laboratory
measurements but to improve clinical care by augmenting the
data available to the clinician for assessment of the patient.
Two preliminary investigations on how SpHb can help guide
transfusion decisions, published thus far only as abstracts,
support this notion.
The first study, a randomized controlled trial in 327 sur-
gery patients with expected low blood, found that when
SpHb monitoring was added to standard care, the frequency
of blood transfusions dropped from 4.5% to 0.6% (87%
decrease) and the mean units transfused dropped from 0.1
to 0.01 units per patient (90% decrease) (Table 1(a)) [18]. The
second prospective cohort study conducted in 106 patients at
risk for high blood loss showed that the addition of SpHb
monitoring to standard care resulted in a reduction from
1.9 ± 2.3 units to 1.0 ± 1.5 units (47% decrease) in the average
number of RBC units transfused and a reduction from 73%
to 32% (56% decrease) in the frequency of multiunit RBC
transfusions (Table 1(b)) [19]. With SpHb monitoring clini-
cians were able to initiate transfusions about 9 minutes faster
compared to physicians not using the technology, because
they did not have to wait for a laboratory haemoglobin value.
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Figure 3: Trend plot of continuous SpHb (red line) and intermittent
laboratory haemoglobin values (tHb, black dots) during spine sur-
gery in a 69-year-old female patient [8].
3. Discussion
The rapid and noninvasive measurement of haemoglobin
and the availability of continuous haemoglobin data have
the potential to be enormously useful in clinical practice in
a variety of situations, such as in trauma, gastrointesti-
nal bleeding, in the perioperative setting, or for guiding blood
management during invasive interventions [20, 21].
The results from evaluations of SpHb with Pulse CO-
Oximetry are promising. In many settings SpHb measure-
ments appear to have similar accuracy as capillary haemo-
globin determination when compared to laboratory analysis.
Nevertheless, there is room for improvement of the tech-
nology (which is on-going), for educating clinician on the
best use of the technology and adapting clinical pathways
to take advantage of this new tool [16]. In the author’s eyes,
because the technology is not intended to replace laboratory
measurements, it is less important to receive a measurement
that exactly mirrors a laboratory value, rather than to provide
continuous information regarding the changes or stability of
haemoglobin. For the spot check applications, the immediacy
of data and noninvasive nature of the device make it ideal for
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prehospital triage decisions such as choosing the right hospi-
tal. At the hospital, this technology has the potential to assist
emergency department staff in making triage priorities and
in assigning staff and infrastructure. The ease of use of these
devices allows for the universal screening of all presenting
patients for anaemia which could indicate occult bleeding or
other disease processes requiring intervention.
More data from prospective studies is needed to confirm
the reliability of this method to guide therapy during surgery
or on-going bleeding. Additionally, prospective randomised
trials would be desirable to investigate the potential of SpHb
monitoring to reduce blood transfusions during surgery or in
the intensive care unit.
In conclusion, SpHb by Pulse CO-Oximeter is a promis-
ing newmedical technology that has the potential to improve
the process of care and patient outcomes in many different
healthcare settings.
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